BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8720306)

  • 21. Stereoselective serum protein binding of ketoprofen in liver diseases.
    Sakai T; Maruyama T; Sako T; Ahmed S; Zuidema X; Fujiyama S; Otagiri M
    Enantiomer; 1999; 4(5):477-82. PubMed ID: 10586515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of drug binding to human serum albumin: allosteric and competitive inhibition at the benzodiazepine binding site by free fatty acids of various chain lengths.
    Menke G; Wörner W; Kratzer W; Rietbrock N
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):42-7. PubMed ID: 2471088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of interaction between drug enantiomers and serum albumin by capillary electrophoresis.
    Ding Y; Zhu X; Lin B
    Electrophoresis; 1999 Jul; 20(9):1890-4. PubMed ID: 10445331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A fluorescence study of human serum albumin binding sites modification by hypochlorite.
    Lissi E; Alicia Biasutti M; Abuin E; León L
    J Photochem Photobiol B; 2009 Feb; 94(2):77-81. PubMed ID: 19036598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereoselective protein binding of ketoprofen: effect of albumin concentration and of the biological system.
    Dubois N; Lapicque F; Abiteboul M; Netter P
    Chirality; 1993; 5(3):126-34. PubMed ID: 8338722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen.
    Yamasaki K; Rahman MH; Tsutsumi Y; Maruyama T; Ahmed S; Kragh-Hansen U; Otagiri M
    AAPS PharmSciTech; 2000 May; 1(2):E12. PubMed ID: 14727845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro enantioselective displacement of propranolol from protein binding sites by acetyl salicylic acid and salicylic acid.
    Rezaei Z; Khabnadideh S; Hemmateenejad B; Dehghani Z
    Int J Pharm; 2007 Sep; 342(1-2):78-81. PubMed ID: 17590545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Albumin binding sites for etodolac enantiomers.
    Mignot I; Presle N; Lapicque F; Monot C; Dropsy R; Netter P
    Chirality; 1996; 8(3):271-80. PubMed ID: 8777148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability.
    Kurono M; Fujii A; Murata M; Fujitani B; Negoro T
    Biochem Pharmacol; 2006 Jan; 71(3):338-53. PubMed ID: 16324683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Species-dependent stereoselective drug binding to albumin: a circular dichroism study.
    Pistolozzi M; Bertucci C
    Chirality; 2008 Mar; 20(3-4):552-8. PubMed ID: 18172833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism.
    Presle N; Lapicque F; Fournel-Gigleux S; Magdalou J; Netter P
    Drug Metab Dispos; 1996 Oct; 24(10):1050-7. PubMed ID: 8894504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enantioselective inhibition of the binding of rac-profens to human serum albumin induced by lithocholate.
    Bertucci C
    Chirality; 2001 Jul; 13(7):372-8. PubMed ID: 11400191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin.
    Lautenslager GT; Shearman CW; Hud E; Cohen MP
    Metabolism; 2011 Dec; 60(12):1683-91. PubMed ID: 21632076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat.
    Jett MF; Ramesha CS; Brown CD; Chiu S; Emmett C; Voronin T; Sun T; O'Yang C; Hunter JC; Eglen RM; Johnson RM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1288-97. PubMed ID: 10027870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of anti-HIV drugs to human serum albumin.
    Bocedi A; Notaril S; Narciso P; Bolli A; Fasano M; Ascenzi P
    IUBMB Life; 2004 Oct; 56(10):609-14. PubMed ID: 15814459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin.
    Bocedi A; Notari S; Menegatti E; Fanali G; Fasano M; Ascenzi P
    FEBS J; 2005 Dec; 272(24):6287-96. PubMed ID: 16336266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of stereoselectivity in the hepatic availability of verapamil in isolated perfused rat livers. Role of protein binding.
    Mehvar R; Reynolds J
    Drug Metab Dispos; 1996 Oct; 24(10):1088-94. PubMed ID: 8894509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective binding and degradation of sulbenicillin in the presence of human serum albumin.
    Tsuda Y; Tsunoi T; Watanabe N; Ishida M; Yamada H; Itoh T
    Chirality; 2001 May; 13(5):236-43. PubMed ID: 11317344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of heme and myristate binding to human serum albumin by anti-HIV drugs. An optical and NMR spectroscopic study.
    Fanali G; Bocedi A; Ascenzi P; Fasano M
    FEBS J; 2007 Sep; 274(17):4491-502. PubMed ID: 17725715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of drug-protein binding by immobilized human serum albumin-HPLC and comparison with ultrafiltration.
    Singh SS; Mehta J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):108-16. PubMed ID: 16567134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.